ABIO logo

ARCA Biopharma (ABIO) Operating Expenses

Annual Operating Expenses

$7.30 M
-$3.30 M-31.14%

December 31, 2023

Summary

Performance

1-Year Change

-31.14%

3-Year Change

-25.29%

5-Year Change

-10.13%

15-Year Change

-61.01%

ABIO Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$144.46 M
ABIO annual total operating expenses is currently -94.95% below its historical high of $144.46 million

3-Year Low

$7.30 M
ABIO annual total operating expenses is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ABIO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ABIO next annual earnings announcement has not yet been scheduled

OtherABIOexpensesmetrics:

Annual Total Expenses

$7.30 M
ABIO annual total expenses is $7.30 million

Annual Interest Expense

-
ABIO annual interest expense value is unknown

Annual Income Tax

-
ABIO annual income tax value is unknown

Annual Cost Of Goods Sold

-
ABIO annual cost of goods sold value is unknown

Quarterly Operating Expenses

$3.12 M
+$640.00 K+25.79%

June 30, 2024

Summary

Performance

3-Month Change

+25.79%

1-Year Change

+96.35%

3-Year Change

-33.8%

5-Year Change

-33.8%

ABIO Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$70.50 M
ABIO quarterly total operating expenses is currently -95.57% below its historical high of $70.50 million

3-Year Low

$1.55 M
ABIO quarterly total operating expenses is currently +101.68% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
ABIO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
ABIO next earnings announcement has not yet been scheduled

OtherABIOexpensesmetrics:

Quarterly Total Expenses

$3.12 M
ABIO quarterly total expenses is $3.12 million

Quarterly Interest Expense

-
ABIO quarterly interest expense value is unknown

Quarterly Income Tax

-
ABIO quarterly income tax value is unknown

Quarterly Cost Of Goods Sold

-
ABIO quarterly cost of goods sold value is unknown

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

Annual Operating Expenses

$7.30 M
ABIO annual total operating expenses is $7.30 million

Annual SGA

$6.28 M
ABIO annual SGA is $6.28 million

Annual D&A

$111.00 K
ABIO annual depreciation & amortization is $111.00 thousand

ABIO Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-31.1%+96.3%
3 y3 years-25.3%-33.8%
5 y5 years-10.1%-33.8%

ABIO Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-62.3%at low-45.0%-50.4%
5 y5-year-62.3%-20.3%-45.0%-59.1%
alltimeall time-94.9%-40.8%-95.6%-775.6%

ARCA Biopharma Operating Expenses History

DateAnnualQuarterly
Jun 2024
-
$3.12 M(+25.8%)
Mar 2024
-
$2.48 M(+56.1%)
Dec 2023
$7.30 M(-31.1%)
$1.59 M(-17.9%)
Sep 2023
-
$1.94 M(-1.8%)
Jun 2023
-
$1.97 M(+9.9%)
Mar 2023
-
$1.80 M(+16.0%)
Dec 2022
$10.60 M(-45.2%)
$1.55 M(-39.3%)
Sep 2022
-
$2.55 M(-20.7%)
Jun 2022
-
$3.22 M(-1.8%)
Mar 2022
-
$3.28 M(-42.3%)
Dec 2021
$19.34 M(+98.0%)
$5.68 M(+20.4%)
Sep 2021
-
$4.72 M(-2.5%)
Jun 2021
-
$4.84 M(+17.9%)
Mar 2021
-
$4.10 M(-20.0%)
Dec 2020
$9.77 M(+68.0%)
$5.13 M(+157.6%)
Sep 2020
-
$1.99 M(+51.9%)
Jun 2020
-
$1.31 M(-2.2%)
Mar 2020
-
$1.34 M(+4.9%)
Dec 2019
$5.81 M(-28.4%)
$1.28 M(+2.5%)
Sep 2019
-
$1.25 M(-17.3%)
Jun 2019
-
$1.51 M(-15.3%)
Mar 2019
-
$1.78 M(+16.6%)
Dec 2018
$8.12 M(-56.6%)
$1.53 M(-8.1%)
Sep 2018
-
$1.66 M(-22.9%)
Jun 2018
-
$2.16 M(-22.3%)
Mar 2018
-
$2.77 M(-35.5%)
Dec 2017
$18.71 M(+12.6%)
$4.30 M(-4.0%)
Sep 2017
-
$4.47 M(-19.5%)
Jun 2017
-
$5.56 M(+26.9%)
Mar 2017
-
$4.38 M(+2.1%)
Dec 2016
$16.61 M(+45.0%)
$4.29 M(-8.9%)
Sep 2016
-
$4.71 M(+19.6%)
Jun 2016
-
$3.94 M(+7.4%)
Mar 2016
-
$3.67 M(+15.5%)
Dec 2015
$11.46 M(+18.2%)
$3.17 M(+12.7%)
Sep 2015
-
$2.82 M(+3.6%)
Jun 2015
-
$2.72 M(-0.9%)
Mar 2015
-
$2.74 M(+5.1%)
Dec 2014
$9.69 M(+39.7%)
$2.61 M(+14.3%)
Sep 2014
-
$2.29 M(-5.0%)
Jun 2014
-
$2.41 M(+0.7%)
Mar 2014
-
$2.39 M(-18.9%)
Dec 2013
$6.94 M(+60.7%)
$2.95 M(+70.8%)
Sep 2013
-
$1.73 M(+44.0%)
Jun 2013
-
$1.20 M(+12.0%)
Mar 2013
-
$1.07 M(+27.5%)
Dec 2012
$4.32 M(-41.3%)
$839.00 K(-9.6%)
Sep 2012
-
$928.00 K(-19.0%)
Jun 2012
-
$1.15 M(-18.6%)
Mar 2012
-
$1.41 M(-14.0%)
Dec 2011
$7.36 M(-19.8%)
$1.63 M(-10.3%)
Sep 2011
-
$1.82 M(+6.9%)
Jun 2011
-
$1.70 M(-22.6%)
Mar 2011
-
$2.20 M(-6.4%)
Dec 2010
$9.18 M
$2.35 M(+11.7%)
DateAnnualQuarterly
Sep 2010
-
$2.11 M(-7.2%)
Jun 2010
-
$2.27 M(-7.3%)
Mar 2010
-
$2.45 M(-71.0%)
Dec 2009
$28.85 M(+48.0%)
$8.45 M(+170.9%)
Sep 2009
-
$3.12 M(-57.7%)
Jun 2009
-
$7.37 M(-25.7%)
Mar 2009
-
$9.92 M(-147.0%)
Dec 2008
$19.49 M(-69.3%)
-$21.09 M(-331.7%)
Sep 2008
-
$9.11 M(+128.8%)
Jun 2008
-
$3.98 M(-76.6%)
Mar 2008
-
$17.00 M(+29.6%)
Dec 2007
$63.42 M(-56.1%)
$13.12 M(-4.2%)
Sep 2007
-
$13.70 M(-26.0%)
Jun 2007
-
$18.51 M(+2.3%)
Mar 2007
-
$18.09 M(-74.3%)
Dec 2006
$144.46 M(+96.3%)
$70.50 M(+137.4%)
Sep 2006
-
$29.70 M(+35.3%)
Jun 2006
-
$21.96 M(-1.5%)
Mar 2006
-
$22.30 M(+1.0%)
Dec 2005
$73.58 M(+50.7%)
$22.08 M(+16.4%)
Sep 2005
-
$18.98 M(+6.4%)
Jun 2005
-
$17.83 M(+19.7%)
Mar 2005
-
$14.89 M(+37.6%)
Dec 2004
$48.84 M(+5.5%)
$10.82 M(+4.8%)
Sep 2004
-
$10.33 M(-3.0%)
Jun 2004
-
$10.65 M(-37.5%)
Mar 2004
-
$17.04 M(+297.1%)
Dec 2003
$46.31 M(-25.1%)
$4.29 M(-60.5%)
Sep 2003
-
$10.86 M(-34.0%)
Jun 2003
-
$16.46 M(+12.0%)
Mar 2003
-
$14.69 M(+17.9%)
Dec 2002
$61.84 M(+3.1%)
$12.47 M(+3.8%)
Sep 2002
-
$12.01 M(-13.6%)
Jun 2002
-
$13.90 M(-42.2%)
Mar 2002
-
$24.07 M(+23.8%)
Dec 2001
$59.96 M(+44.6%)
$19.45 M(+37.7%)
Sep 2001
-
$14.13 M(-1.4%)
Jun 2001
-
$14.33 M(+18.9%)
Mar 2001
-
$12.05 M(-14.1%)
Dec 2000
$41.46 M(+41.5%)
$14.04 M(+38.5%)
Sep 2000
-
$10.13 M(+13.8%)
Jun 2000
-
$8.90 M(+6.3%)
Mar 2000
-
$8.38 M(+13.2%)
Dec 1999
$29.30 M(-4.6%)
$7.40 M(+8.8%)
Sep 1999
-
$6.80 M(+1.5%)
Jun 1999
-
$6.70 M(-21.2%)
Mar 1999
-
$8.50 M(+4.9%)
Dec 1998
$30.70 M(+98.1%)
$8.10 M(0.0%)
Sep 1998
-
$8.10 M(+3.8%)
Jun 1998
-
$7.80 M(+16.4%)
Mar 1998
-
$6.70 M(+26.4%)
Dec 1997
$15.50 M(+167.2%)
$5.30 M(+8.2%)
Sep 1997
-
$4.90 M(+75.0%)
Jun 1997
-
$2.80 M(+16.7%)
Mar 1997
-
$2.40 M
Dec 1996
$5.80 M
-

FAQ

  • What is ARCA biopharma annual total operating expenses?
  • What is the all time high annual operating expenses for ARCA biopharma?
  • What is ARCA biopharma annual operating expenses year-on-year change?
  • What is ARCA biopharma quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for ARCA biopharma?
  • What is ARCA biopharma quarterly operating expenses year-on-year change?

What is ARCA biopharma annual total operating expenses?

The current annual operating expenses of ABIO is $7.30 M

What is the all time high annual operating expenses for ARCA biopharma?

ARCA biopharma all-time high annual total operating expenses is $144.46 M

What is ARCA biopharma annual operating expenses year-on-year change?

Over the past year, ABIO annual total operating expenses has changed by -$3.30 M (-31.14%)

What is ARCA biopharma quarterly total operating expenses?

The current quarterly operating expenses of ABIO is $3.12 M

What is the all time high quarterly operating expenses for ARCA biopharma?

ARCA biopharma all-time high quarterly total operating expenses is $70.50 M

What is ARCA biopharma quarterly operating expenses year-on-year change?

Over the past year, ABIO quarterly total operating expenses has changed by +$1.53 M (+96.35%)